Home > Boards > US Listed > Medical - Drugs > Medicis Pharmaceutical (MRX)

Deutsche Bank is out with its report today

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
christinat Member Profile
 
Followed By 0
Posts 43
Boards Moderated 0
Alias Born 07/14/10
160x600 placeholder
christinat   Monday, 02/28/11 10:57:12 AM
Re: None
Post # of 149 
Deutsche Bank is out with its report today on Medicis Pharmaceutical (NYSE: MRX), raising its price target from $35 to $36.

In a note to clients, Deutsche Bank writes, "We are updating our model based on trends for currently marketed products and the discontinuation of LipoSonix and Plexion. We are modestly lowering our EPS ests from $2.53 to $2.51 in 2011, $2.85 to $2.80 in 2012, and $3.19 to $3.14 in 2013. Our new 12-month PT is $36, based on 13x our new 2012 EPS est. Potential risks to our PT being achieved principally relate to the aesthetic franchises and Rx trends for Solodyn and Ziana."


Read more: http://www.benzinga.com/analyst-ratings/analyst-color/11/02/889975/update-deutsche-bank-raises-pt-on-medicis-pharmaceutical-#ixzz1FGmXw0Qd

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist